Here’s Why BioXcel Therapeutics Stock Got Hammered This Week
Investors weren’t happy about a secondary share offering.
‘The Ice Road’: Go Truck Yourself
Let’s just say that this thriller about big-rig haulers navigating slippery, frosty terrain is on thin ice in more…
High-frequency trading and networked markets [Social Sciences]
During the last two decades, technological innovation and regulatory requirements have deeply changed the way financial markets…
Aima Technology Launches IPO on SSE, Hitting Upper Limit on First Day of Trading
On June 15, Aima Technology (SHA:603529), a leading Chinese e-bike manufacturer, announced its Initial Public Offering (IPO)…
Jay Powell’s Taking Out The Trash And Crypto’s First to Go
Stock prices move based on what a company earns and stories about what that company will earn in the…
UiPath: Sell Now Before Profits Evaporate
We urge investors to take profits as UiPath shares will likely contract from current levels driven by lockup expiration,…
FedEx slumps as the carrier beats earnings estimates but says costs tied to increased shipping demand and labor are soaring
After a long run of strong earnings, FedEx disappointed some analysts by coming in just a few cents above…
Federal Reserve Watch: The Fed Has A Dilemma Buying And Selling Securities
This past week, the effective federal funds rate rose for the first time this year, reflecting Fed efforts to…
Senseonics and Clovis Oncology gain ahead of inclusion in Russell Indexes
After a six-day losing streak that led the company to lose nearly a fifth of its value, the maker…
PharmEasy buys 66% stake in Thyrocare
The Thyrocare stock surged 6.23% to ₹1,448.05 on BSE. The announcement was made after the end of trading…
recent post
-
Jun 09 2025 -
Jun 09 2025
-
Jun 09 2025
-
Jun 09 2025
-
Jun 09 2025
